386877005: Irbesartan (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Substance with renin-angiotensin system inhibitor mechanism of action (substance)\Angiotensin II receptor antagonist\Irbesartan (substance)
\Substance categorized by disposition\Substance with receptor antagonist mechanism of action (substance)\Antihormone\Angiotensin II receptor antagonist\Irbesartan (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Cardiovascular agent (substance)\Hypotensive agent (substance)\Substance with renin-angiotensin system inhibitor mechanism of action (substance)\Angiotensin II receptor antagonist\Irbesartan (substance)
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Antihormone\Angiotensin II receptor antagonist\Irbesartan (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Azole\Tetrazole (substance)\Irbesartan (substance)

\Organic compound\Organic cyclic compound\Heterocyclic compound\Azole\Tetrazole (substance)\Irbesartan (substance)
\Organic compound\Organic nitrogen compound\Azole\Tetrazole (substance)\Irbesartan (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Irbesartan (substance)	Is a	Angiotensin II receptor antagonist	true	Inferred relationship	Some
Irbesartan (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Angiotensin II receptor antagonist (disposition)	true	Inferred relationship	Some
Irbesartan (substance)	Is a	Tetrazole (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing irbesartan (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Irbesartan (substance)	Inferred relationship	Some	1
Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Irbesartan (substance)	Inferred relationship	Some
Hydrochlorothiazide 12.5 mg and irbesartan 150 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Irbesartan (substance)	Inferred relationship	Some
Irbesartan 75 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Irbesartan (substance)	Inferred relationship	Some
Irbesartan 150 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Irbesartan (substance)	Inferred relationship	Some
Irbesartan 300 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Irbesartan (substance)	Inferred relationship	Some
Hydrochlorothiazide + irbesartan 12.5mg/150mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Irbesartan (substance)	Inferred relationship	Some
Product containing hydrochlorothiazide and irbesartan (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Irbesartan (substance)	Inferred relationship	Some	1
Adverse reaction caused by irbesartan (disorder)	Causative agent (attribute)	True	Irbesartan (substance)	Inferred relationship	Some	1
Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Irbesartan (substance)	Inferred relationship	Some	2
Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Irbesartan (substance)	Inferred relationship	Some	2
Hydrochlorothiazide 12.5 mg and irbesartan 150 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Irbesartan (substance)	Inferred relationship	Some	1
Irbesartan 75 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Irbesartan (substance)	Inferred relationship	Some	1
Irbesartan 75 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Irbesartan (substance)	Inferred relationship	Some	1
Irbesartan 150 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Irbesartan (substance)	Inferred relationship	Some	1
Irbesartan 150 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Irbesartan (substance)	Inferred relationship	Some	1
Irbesartan 300 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Irbesartan (substance)	Inferred relationship	Some	1
Irbesartan 300 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Irbesartan (substance)	Inferred relationship	Some	1
Hydrochlorothiazide 12.5 mg and irbesartan 150 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Irbesartan (substance)	Inferred relationship	Some	2
Hydrochlorothiazide 12.5 mg and irbesartan 150 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Irbesartan (substance)	Inferred relationship	Some	2
Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Irbesartan (substance)	Inferred relationship	Some	1
Irbesartan hydrochloride (substance)	Is a	False	Irbesartan (substance)	Inferred relationship	Some
Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Irbesartan (substance)	Inferred relationship	Some	1
Irbesartan 75 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Irbesartan (substance)	Inferred relationship	Some	1
Hydrochlorothiazide 12.5 mg and irbesartan 150 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Irbesartan (substance)	Inferred relationship	Some	1
Irbesartan 150 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Irbesartan (substance)	Inferred relationship	Some	1
Irbesartan 300 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Irbesartan (substance)	Inferred relationship	Some	1
Hydrochlorothiazide- and irbesartan-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Irbesartan (substance)	Inferred relationship	Some	1
Product containing irbesartan in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Irbesartan (substance)	Inferred relationship	Some	1
Irbesartan only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Irbesartan (substance)	Inferred relationship	Some	1
Hydrochlorothiazide and irbesartan only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Irbesartan (substance)	Inferred relationship	Some	1
Product containing only irbesartan in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Irbesartan (substance)	Inferred relationship	Some	1
Hydrochlorothiazide and irbesartan only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Irbesartan (substance)	Inferred relationship	Some	1
Irbesartan hydrochloride (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Irbesartan (substance)	Inferred relationship	Some
Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan (as irbesartan hydrochloride) 150 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Irbesartan (substance)	Inferred relationship	Some	1
Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan (as irbesartan hydrochloride) 300 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Irbesartan (substance)	Inferred relationship	Some	1
Product containing precisely hydrochlorothiazide 25 milligram and irbesartan (as irbesartan hydrochloride) 300 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Irbesartan (substance)	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1461055010	Irbesartan (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1480991015	Irbesartan	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
51901000195116	irbesartan	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
818621000172112	irbésartan	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
67031000195112	Irbesartan	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module